Literature DB >> 25171470

Medical research: Ebola therapy protects severely ill monkeys.

Thomas W Geisbert1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25171470      PMCID： PMC4469351          DOI： 10.1038/nature13746

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  14 in total

1.  Advanced antisense therapies for postexposure protection against lethal filovirus infections.

Authors:  Travis K Warren; Kelly L Warfield; Jay Wells; Dana L Swenson; Kelly S Donner; Sean A Van Tongeren; Nicole L Garza; Lian Dong; Dan V Mourich; Stacy Crumley; Donald K Nichols; Patrick L Iversen; Sina Bavari
Journal:  Nat Med       Date:  2010-08-22       Impact factor: 53.440

2.  Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany.

Authors:  Stephan Günther; Heinz Feldmann; Thomas W Geisbert; Lisa E Hensley; Pierre E Rollin; Stuart T Nichol; Ute Ströher; Harvey Artsob; Clarence J Peters; Thomas G Ksiazek; Stephan Becker; Jan ter Meulen; Stephan Olschläger; Jonas Schmidt-Chanasit; Hinrich Sudeck; Gerd D Burchard; Stefan Schmiedel
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

3.  Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies.

Authors:  Xiangguo Qiu; Jonathan Audet; Gary Wong; Stephane Pillet; Alexander Bello; Teresa Cabral; Jim E Strong; Frank Plummer; Cindy R Corbett; Judie B Alimonti; Gary P Kobinger
Journal:  Sci Transl Med       Date:  2012-06-13       Impact factor: 17.956

4.  Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease.

Authors:  John M Dye; Andrew S Herbert; Ana I Kuehne; James F Barth; Majidat A Muhammad; Samantha E Zak; Ramon A Ortiz; Laura I Prugar; William D Pratt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-12       Impact factor: 11.205

5.  Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys.

Authors:  Thomas W Geisbert; Lisa E Hensley; Peter B Jahrling; Tom Larsen; Joan B Geisbert; Jason Paragas; Howard A Young; Terry M Fredeking; William E Rote; George P Vlasuk
Journal:  Lancet       Date:  2003-12-13       Impact factor: 79.321

6.  Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques.

Authors:  Gene Garrard Olinger; James Pettitt; Do Kim; Cara Working; Ognian Bohorov; Barry Bratcher; Ernie Hiatt; Steven D Hume; Ashley K Johnson; Josh Morton; Michael Pauly; Kevin J Whaley; Calli M Lear; Julia E Biggins; Corinne Scully; Lisa Hensley; Larry Zeitlin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-15       Impact factor: 11.205

7.  Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail.

Authors:  James Pettitt; Larry Zeitlin; Do H Kim; Cara Working; Joshua C Johnson; Ognian Bohorov; Barry Bratcher; Ernie Hiatt; Steven D Hume; Ashley K Johnson; Josh Morton; Michael H Pauly; Kevin J Whaley; Michael F Ingram; Ashley Zovanyi; Megan Heinrich; Ashley Piper; Justine Zelko; Gene G Olinger
Journal:  Sci Transl Med       Date:  2013-08-21       Impact factor: 17.956

8.  Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever.

Authors:  Lisa E Hensley; Edward L Stevens; S Betty Yan; Joan B Geisbert; William L Macias; Tom Larsen; Kathleen M Daddario-DiCaprio; Gail H Cassell; Peter B Jahrling; Thomas W Geisbert
Journal:  J Infect Dis       Date:  2007-11-15       Impact factor: 5.226

9.  Effective post-exposure treatment of Ebola infection.

Authors:  Heinz Feldmann; Steven M Jones; Kathleen M Daddario-DiCaprio; Joan B Geisbert; Ute Ströher; Allen Grolla; Mike Bray; Elizabeth A Fritz; Lisa Fernando; Friederike Feldmann; Lisa E Hensley; Thomas W Geisbert
Journal:  PLoS Pathog       Date:  2007-01       Impact factor: 6.823

10.  Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study.

Authors:  Thomas W Geisbert; Amy C H Lee; Marjorie Robbins; Joan B Geisbert; Anna N Honko; Vandana Sood; Joshua C Johnson; Susan de Jong; Iran Tavakoli; Adam Judge; Lisa E Hensley; Ian Maclachlan
Journal:  Lancet       Date:  2010-05-29       Impact factor: 79.321
View more
  7 in total

Review 1.  Ebola Virus Disease: Focus on Children.

Authors:  Athena P Kourtis; Kristie Appelgren; Michelle S Chevalier; Anita McElroy
Journal:  Pediatr Infect Dis J       Date:  2015-08       Impact factor: 2.129

Review 2.  Innate immune evasion by filoviruses.

Authors:  Christopher F Basler
Journal:  Virology       Date:  2015-04-03       Impact factor: 3.616

3.  Expression of H3N2 nucleoprotein in maize seeds and immunogenicity in mice.

Authors:  Hartinio N Nahampun; Brad Bosworth; Joan Cunnick; Mark Mogler; Kan Wang
Journal:  Plant Cell Rep       Date:  2015-02-13       Impact factor: 4.570

4.  Ebola viral disease outbreak-2014: implications and pitfalls.

Authors:  Mahip Acharya
Journal:  Front Public Health       Date:  2014-12-01

5.  Ebola Virus Infections in Nonhuman Primates Are Temporally Influenced by Glycoprotein Poly-U Editing Site Populations in the Exposure Material.

Authors:  John C Trefry; Suzanne E Wollen; Farooq Nasar; Joshua D Shamblin; Steven J Kern; Jeremy J Bearss; Michelle A Jefferson; Taylor B Chance; Jeffery R Kugelman; Jason T Ladner; Anna N Honko; Dean J Kobs; Morgan Q S Wending; Carol L Sabourin; William D Pratt; Gustavo F Palacios; M Louise M Pitt
Journal:  Viruses       Date:  2015-12-19       Impact factor: 5.048

6.  Urgent development of effective therapeutic and prophylactic agents to control the emerging threat of Middle East respiratory syndrome (MERS).

Authors:  Lu Lu; Shuai Xia; Tianlei Ying; Shibo Jiang
Journal:  Emerg Microbes Infect       Date:  2015-06-17       Impact factor: 7.163

7.  The Myeloid LSECtin Is a DAP12-Coupled Receptor That Is Crucial for Inflammatory Response Induced by Ebola Virus Glycoprotein.

Authors:  Dianyuan Zhao; Xintao Han; Xuexing Zheng; Hualei Wang; Zaopeng Yang; Di Liu; Ke Han; Jing Liu; Xiaowen Wang; Wenting Yang; Qingyang Dong; Songtao Yang; Xianzhu Xia; Li Tang; Fuchu He
Journal:  PLoS Pathog       Date:  2016-03-04       Impact factor: 6.823
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.